What caused MLCAC.PA stock to drop today?

The intraday drop to €14.10 reflects thin trading, profit-taking after a €16.40 open, and sensitivity to EPS swings given low liquidity. No major company announcement was posted during the session.

Is MLCAC.PA stock cheap compared with peers?

Price-to-book at 0.50 and P/S at 0.61 look cheap, but the quoted PE near 100.71 reflects very low EPS. Compare cautiously to sector PE of 24.21 because profitability is much weaker.

What is Meyka AI’s view and forecast for MLCAC.PA stock?

Meyka AI rates MLCAC.PA **63.40 (B, HOLD)**. The model projects a yearly price of €15.17, implying about 7.59% upside versus €14.10. Forecasts are model-based projections and not guarantees.

What are the key levels to watch for traders?

Watch immediate support at €14.10 and the 50-day average near €14.55. Key resistance sits at €16.40 and the year high €16.80. Monitor volume closely due to thin liquidity.

EU Stocks

MLCAC.PA Lombard & Medot (EURONEXT) down 9.62% intraday 23 Feb 2026: monitor €14.10 support

ByDanny Kontos February 23, 2026

The MLCAC.PA stock tumbled 9.62% intraday on EURONEXT to €14.10 on 23 Feb 2026, making it one of Europe’s top losers in the Consumer Defensive sector. The drop follows an early open at €16.40 and a day high of €16.40, confirming heavy profit-taking. Volume is light at 6.00 shares traded, but the move widened the gap versus the 50-day average €14.55. We assess valuation, technical support, and Meyka AI forecasts to show where Lombard & Medot SA may trade next and which risks to monitor